Skip to main content
Clinical Trials/NCT07240961
NCT07240961RecruitingNot Applicable

Ultrasound-Guided Lumbal Erector Spinae Plane Block on Postoperative Pain Management After Total Hip Arthroplasty

University Tunis El Manar1 site in 1 country60 target enrollmentStarted: November 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
morphine consumption

Study Overview

Brief Summary

The Erector Spinae Plane (ESP) block or spinal erector block was first described in September 2016 by a Canadian team. It's a block that was initially used for the treatment of chronic thoracic neuropathic pain. The ESP block is one of the inter-fascicular blocks and it's an easy-to-perform technique.In the literature, it has been reported that Lumbar ESPB provides effective analgesia after a hip surgery.

The purpose of this prospective randomized study was to compare the analgesic effects of the ultrasound-guided lumbar Erector Spinae Plane block on postoperative pain management versus the multimodal analgesia after total hip arthroplasty.

Detailed Description

Patients aged more than 18 years, ASA I-III scheduled for primary total hip arthroplasty with lateral approach and under general anesthesia Patients were randomly assigned, into 1 of 2 groups, namely, group ESPBL and group Placebo, using sealed envelopes

  • For ESPBL group: Lumbar ESP block performed after anesthesia induction. A low-frequency ultrasound probe will be placed longitudinally 2-3 cm lateral to the L4 transverse process. Erector spinae muscle will be visualized on the hyperechoic transverse process. The block needle (100 mm, 22G) will be inserted cranio-caudal direction and following confirmation of the correct position of the needle, between the erectorspinae muscle and the transverse process,30 ml of local anesthetic (0.25% bupivacaine/0.2% ropivacaine) will be administered for the block.
  • For Placebo group: patients had multimodal analgesia without lumbar ESP block Patients will be transferred to continuous care unit for 24 hours.

Post-operative analgesia will include:

  1. Paracetamol 1g IV every 8 hours for 1 day then oral paracetamol 1g every 8 hours for 4 weeks.
  2. Diclofenac sodium(50mg) 1 tablet x 2 per day for 5 days.
  3. PCA morphine (Patient Controlled Analgesia), as a rescue analgesia, programmed as: Bolus of 1mg/ refractory period of 10 min/ maximum dose set up at 10mg every 12h.

The primary outcome of the study is to compare postoperative opioids consumption in the first 24 postoperative hours.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Sequential
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •primary total hip arthroplasty with lateral approach and under general anesthesia .

Exclusion Criteria

  • •• Contraindication or refusal to regional anesthesia
  • •Contraindication to non-steroidal anti-inflammatory (NSAID's)
  • •Allergy to opioids
  • •Allergy to paracetamol
  • •Creatinine clearance < 30ml/min
  • •Weight<50 kg or >100kg
  • •Psychiatric disorders and difficulty of communication
  • •Lower limb neurological deficit
  • •Patients undergoing bilateral or revision total hip replacement

Arms & Interventions

hip arthroplasty with nerve block

Active Comparator

Lumbar ESP block performed after anesthesia induction. A low-frequency ultrasound probe will be placed longitudinally 2-3 cm lateral to the L4 transverse process. Erector spinae muscle will be visualized on the hyperechoic transverse process. The block needle (100 mm, 22G) will be inserted cranio-caudal direction and following confirmation of the correct position of the needle, between the erectorspinae muscle and the transverse process,30 ml of local anesthetic (0.25% bupivacaine/0.2% ropivacaine) will be administered for the block

Intervention: Lumbal Erector Spinae Plane Block (Procedure)

hip arthroplasty with intravenous pain killers

Placebo Comparator

intravenous pain killers

Intervention: intravenous pain killers (Procedure)

Outcomes

Primary Outcomes

morphine consumption

Time Frame: Day 1

total morphine dose

Secondary Outcomes

  • pain scores(Hour 2, Hour 4, Hour 6, Hour 12, Hour 18, Hour 24 and on Day 2 and Day 7.)
  • intraoperative opioid consumption(end of surgery)
  • pain on sitting position(Day 1)
  • QR 9 score(Day 2)
  • ROM(Day 1)
  • pain during walk(Day 7)

Investigators

Sponsor
University Tunis El Manar
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Olfa kaabachi, MD

professor

University Tunis El Manar

Study Sites (1)

Loading locations...

Similar Trials